**
People suffering from hypermobility conditions in the UK are facing alarming delays—sometimes extending to 21 years—before receiving a formal diagnosis, according to a new study. This extensive research, the most comprehensive of its kind in the UK, reveals that many individuals endure a range of debilitating symptoms, including chronic pain and joint dislocation, while encountering a significant lack of awareness about these conditions among healthcare professionals.
An Alarming Delay in Diagnosis
The study, conducted by researchers at the University of Edinburgh and involving over 2,000 participants, highlights a troubling trend: the prolonged “diagnostic journey” for those with hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS). These disorders, which affect connective tissue throughout the body, are characterised by joint hypermobility and a host of systemic issues, including fatigue, gastrointestinal problems, and neurological symptoms.
Notably, the study participants reported an overwhelming prevalence of chronic pain, with 84% affected, while nearly three-quarters experienced partially dislocated joints. In addition, mental health issues are rampant: 71% reported anxiety and 63% experienced depression, illustrating the far-reaching impact of these conditions on everyday life.
Fragmented Healthcare Experiences
The research underscores the fragmented nature of healthcare that patients navigate when seeking a diagnosis. According to Kathryn Berg, trial and data manager at the university’s Institute of Genetics and Cancer, the findings shine a light on the urgent need for cohesive, multidisciplinary care pathways that acknowledge the complex nature of these disorders. She stated, “This study highlights the profound impact hEDS and HSD can have across every aspect of life.”
The data reveals that nearly half of the respondents were unemployed, and many were receiving disability-related benefits. A staggering 56% reported disruptions in their education, indicating that the lack of timely and effective healthcare has repercussions beyond physical health, affecting mental well-being, career prospects, and academic achievement.
Regional Disparities in Diagnosis
The study also pointed to significant regional disparities in the diagnostic timeline. Participants from Wales reported the longest wait, averaging 21.7 years from the onset of symptoms to diagnosis. Comparatively, those in Northern Ireland waited an average of 21.1 years, while Scots faced a wait of 19.5 years and individuals in England endured 19 years.
Even more disheartening, many patients have had to travel across the UK for assessments, with over a third of Welsh and Northern Irish respondents leaving their home regions to seek diagnosis elsewhere. In Scotland, 17% of participants faced similar challenges, while 98% of those in England received their diagnosis within their home country.
Responding to the Crisis
In light of these findings, a Welsh government spokesperson acknowledged the challenges faced by patients in Wales and is actively pursuing a clinical endorsement for a proposed community health pathway. This initiative aims to streamline the diagnostic process and improve access to specialist care for those affected.
Meanwhile, the UK government has recognised the importance of addressing the needs of individuals with hypermobility disorders. A spokesperson stated, “People living with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders deserve to have their symptoms recognised and taken seriously.” They noted the availability of a toolkit developed by the Royal College of General Practitioners, in collaboration with EDS Support UK, designed to enhance awareness and consistency in managing these complex conditions.
Why it Matters
The prolonged waits for diagnosis and treatment of hypermobility disorders reflect a significant gap in healthcare that can have life-altering consequences for patients. With a considerable portion of the population suffering from chronic pain and mental health issues, it is crucial to enhance awareness among healthcare professionals. This not only affects the individuals living with these conditions but also highlights systemic issues within the healthcare framework that demand urgent reform. The call for more inclusive and informed healthcare pathways is not just a matter of patient care—it is an essential step toward ensuring dignity and quality of life for those affected.
